ArticleJournal of diabetes investigation2026
Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis.
Kun Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.